5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine
An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer.
| Supplier | BOC Sciences |
|---|---|
| Product # | B1476-284923 |
| Pricing | 100 mg/unit USD $1293 |
| Cas | 1823404-28-9 |
| Molecular Weight | 276.56 |
| Molecular Formula | C9H11BrClN3 |
| Canonical SMILES | C1CCC(C1)NC2=NC=C(C(=N2)Cl)Br |